Pharmaceutical Preparations · DE · CIK 1724521
Arcus Biosciences, Inc. develops and commercializes novel immunotherapies for cancer
Comparable business profile · signals at a glance
In the 90 days to Jan 5, 2026: 7 sold $10.9M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 5, 2026 | Jaen Juan C.President | Sell | 29,670 | $21.34 | $633K |
| Jan 5, 2026 | Jaen Juan C.President | Sell | 2,053 | $22.34 | $46K |
| Jan 5, 2026 | Jaen Juan C.President | Sell | 100 | $23.20 | $2K |
| Dec 31, 2025 | Goeltz Ii Robert C.Chief Financial Officer | Sell | 6,552 | $23.38 | $153K |
| Dec 18, 2025 | Azoy AlexanderChief Accounting Officer | Sell | 4,343 | $22.25 | $97K |
| Dec 17, 2025 | Rosen Terry JChief Executive Officer | Sell | 25,744 | $22.16 | $570K |
| Dec 17, 2025 | Jarrett JenniferChief Operating Officer | Sell | 9,983 | $22.16 | $221K |
| Dec 17, 2025 | Jaen Juan C.President | Sell | 9,983 | $22.16 | $221K |
| Dec 17, 2025 | Tang Carolyn C.General Counsel | Sell | 6,810 | $22.16 | $151K |
| Dec 17, 2025 | Goeltz Ii Robert C.Chief Financial Officer | Sell | 5,960 | $22.16 | $132K |
| Dec 17, 2025 | Markus RichardChief Medical Officer | Sell | 4,494 | $22.16 | $100K |
| Dec 17, 2025 | Azoy AlexanderChief Accounting Officer | Sell | 2,113 | $22.16 | $47K |
| Dec 16, 2025 | Rosen Terry JChief Executive Officer | Sell | 28,947 | $21.88 | $633K |
| Dec 16, 2025 | Jarrett JenniferChief Operating Officer | Sell | 11,225 | $21.88 | $246K |
| Dec 16, 2025 | Jaen Juan C.President | Sell | 11,225 | $21.88 | $246K |
| Dec 16, 2025 | Tang Carolyn C.General Counsel | Sell | 7,658 | $21.88 | $168K |
| Dec 16, 2025 | Goeltz Ii Robert C.Chief Financial Officer | Sell | 6,702 | $21.88 | $147K |
| Dec 16, 2025 | Markus RichardChief Medical Officer | Sell | 5,052 | $21.88 | $111K |
| Dec 16, 2025 | Azoy AlexanderChief Accounting Officer | Sell | 2,376 | $21.88 | $52K |
| Dec 4, 2025 | Jaen Juan C.President | Sell | 82,997 | $24.71 | $2.1M |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.